| Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy MS Maron, I Olivotto, S Betocchi, SA Casey, JR Lesser, MA Losi, F Cecchi, ... New England Journal of Medicine 348 (4), 295-303, 2003 | 1656 | 2003 |
| Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction S Grifoni, I Olivotto, P Cecchini, F Pieralli, A Camaiti, G Santoro, A Conti, ... Circulation 101 (24), 2817-2822, 2000 | 1167 | 2000 |
| Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction MS Maron, I Olivotto, AG Zenovich, MS Link, NG Pandian, JT Kuvin, ... Circulation 114 (21), 2232-2239, 2006 | 1117 | 2006 |
| Epidemiology of hypertrophic cardiomyopathy–related death: revisited in a large non–referral-based patient population BJ Maron, I Olivotto, P Spirito, SA Casey, P Bellone, TE Gohman, ... Circulation 102 (8), 858-864, 2000 | 1022 | 2000 |
| Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy I Olivotto, F Cecchi, SA Casey, A Dolara, JH Traverse, BJ Maron Circulation 104 (21), 2517-2524, 2001 | 1017 | 2001 |
| Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy RH Chan, BJ Maron, I Olivotto, MJ Pencina, GE Assenza, T Haas, ... Circulation 130 (6), 484-495, 2014 | 940 | 2014 |
| Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy F Cecchi, I Olivotto, R Gistri, R Lorenzoni, G Chiriatti, PG Camici New England Journal of Medicine 349 (11), 1027-1035, 2003 | 872 | 2003 |
| Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy SR Ommen, BJ Maron, I Olivotto, MS Maron, F Cecchi, S Betocchi, ... Journal of the American College of Cardiology 46 (3), 470-476, 2005 | 857 | 2005 |
| Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine BJ Maron, SR Ommen, C Semsarian, P Spirito, I Olivotto, MS Maron Journal of the American College of Cardiology 64 (1), 83-99, 2014 | 702 | 2014 |
| Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial I Olivotto, A Oreziak, R Barriales-Villa, TP Abraham, A Masri, ... The Lancet 396 (10253), 759-769, 2020 | 687 | 2020 |
| Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe) CY Ho, SM Day, EA Ashley, M Michels, AC Pereira, D Jacoby, AL Cirino, ... Circulation 138 (14), 1387-1398, 2018 | 585 | 2018 |
| Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance MS Maron, BJ Maron, C Harrigan, J Buros, CM Gibson, I Olivotto, L Biller, ... Journal of the American College of Cardiology 54 (3), 220-228, 2009 | 551 | 2009 |
| Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy I Olivotto, MS Maron, AS Adabag, SA Casey, D Vargiu, MS Link, ... Journal of the American College of Cardiology 46 (3), 480-487, 2005 | 479 | 2005 |
| Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy BJ Maron, I Olivotto, P Bellone, MR Conte, F Cecchi, BP Flygenring, ... Journal of the American College of Cardiology 39 (2), 301-307, 2002 | 478 | 2002 |
| Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy MS Maron, I Olivotto, C Harrigan, E Appelbaum, CM Gibson, JR Lesser, ... Circulation 124 (1), 40-47, 2011 | 446 | 2011 |
| Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy I Olivotto, F Girolami, MJ Ackerman, S Nistri, JM Bos, E Zachara, ... Mayo Clinic Proceedings 83 (6), 630-638, 2008 | 440 | 2008 |
| Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study DA Hughes, K Nicholls, SP Shankar, G Sunder-Plassmann, D Koeller, ... Journal of medical genetics 54 (4), 288-296, 2017 | 436 | 2017 |
| Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport … A Pelliccia, EE Solberg, M Papadakis, PE Adami, A Biffi, S Caselli, ... European Heart Journal 40 (1), 19-33, 2019 | 428 | 2019 |
| Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy R Coppini, C Ferrantini, L Yao, P Fan, M Del Lungo, F Stillitano, L Sartiani, ... Circulation 127 (5), 575-584, 2013 | 423 | 2013 |
| 2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC) E Arbelo, A Protonotarios, JR Gimeno, E Arbustini, R Barriales-Villa, ... European heart journal 44 (37), 3503-3626, 2023 | 414 | 2023 |
